Answers are grounded in this paper and cite their sources.
Predicting gene expression from whole genome sequencing data is essential for elucidating regulatory mechanisms and interpreting functional consequences of non-coding variants to complex diseases. While traditional approaches rely on variant-based linear models, DNA sequence-based language models have gained increasing popularity for their ability to learn regulatory features directly from whole genome sequence data. Previous studies have evaluated models such as Enformer, but newer sequence-to-function models, including Borzoi and AlphaGenome, remain less well characterized for individual-level gene expression prediction, particularly in non-European and admixed populations. Here, we evaluated and fine-tuned Borzoi and AlphaGenome using personal genomes paired with whole-blood RNA-seq data from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Fine-tuning substantially improved the performance of both sequence-based models compared with their pretrained versions; however, their performances remained similar to that of the variant-based linear models. Leveraging the ancestral diversity of HCHS/SOL, we found that Borzoi and AlphaGenome showed similar performance across Amerindian-, European-, and African-enriched groups. Fine-tuned Borzoi, fine-tuned AlphaGenome and elastic net performed modestly better when trained and evaluated in the same ancestry-enriched group. Finally, we explored strategies to improve prediction performance and found that incorporating predicted epigenetic features improved prediction near the promoter region. Significant progress remains needed before the full potential of sequence-based models is attained. Incorporating more biology-guided training approaches could be helpful to achieving better performance.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: